
### [MONDO:0000653](http://purl.obolibrary.org/obo/MONDO_0000653)
**Label:** integumentary system cancer

**Subclasses:** [MONDO:0013133](http://purl.obolibrary.org/obo/MONDO_0013133) (melanoma, cutaneous malignant, susceptibility to, 5), [MONDO:0018785](http://purl.obolibrary.org/obo/MONDO_0018785) (nodular fasciitis), [MONDO:0019476](http://purl.obolibrary.org/obo/MONDO_0019476) (primary cutaneous peripheral T-cell lymphoma not otherwise specified), [MONDO:0019475](http://purl.obolibrary.org/obo/MONDO_0019475) (subcutaneous panniculitis-like T-cell lymphoma), [MONDO:0019472](http://purl.obolibrary.org/obo/MONDO_0019472) (extranodal nasal NK/T cell lymphoma), [MONDO:0019471](http://purl.obolibrary.org/obo/MONDO_0019471) (adult T-cell leukemia/lymphoma), [MONDO:0007965](http://purl.obolibrary.org/obo/MONDO_0007965) (melanoma, malignant familial intraocular), [MONDO:0007964](http://purl.obolibrary.org/obo/MONDO_0007964) (dysplastic nevus syndrome), [MONDO:0005103](http://purl.obolibrary.org/obo/MONDO_0005103) (well-differentiated liposarcoma), [MONDO:0007963](http://purl.obolibrary.org/obo/MONDO_0007963) (CMM1), [MONDO:0011556](http://purl.obolibrary.org/obo/MONDO_0011556) (BCC1), [MONDO:0012842](http://purl.obolibrary.org/obo/MONDO_0012842) (CMM7), [MONDO:0005060](http://purl.obolibrary.org/obo/MONDO_0005060) (liposarcoma), [MONDO:0011954](http://purl.obolibrary.org/obo/MONDO_0011954) (CMM4), [MONDO:0015758](http://purl.obolibrary.org/obo/MONDO_0015758) (primary cutaneous T-cell lymphoma), [MONDO:0014299](http://purl.obolibrary.org/obo/MONDO_0014299) (Schwannomatosis 2), [MONDO:0017844](http://purl.obolibrary.org/obo/MONDO_0017844) (Sezary syndrome), [MONDO:0018897](http://purl.obolibrary.org/obo/MONDO_0018897) (primary cutaneous CD30+ T-cell lymphoproliferative disease), [MONDO:0015820](http://purl.obolibrary.org/obo/MONDO_0015820) (primary cutaneous b-cell lymphoma), [MONDO:0018898](http://purl.obolibrary.org/obo/MONDO_0018898) (primary cutaneous lymphoma), [MONDO:0014056](http://purl.obolibrary.org/obo/MONDO_0014056) (melanoma, cutaneous malignant, susceptibility to, 9), [MONDO:0008057](http://purl.obolibrary.org/obo/MONDO_0008057) (Carney complex, type 1), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0009227](http://purl.obolibrary.org/obo/MONDO_0009227) (myofibromatosis, infantile, 1), [MONDO:0016071](http://purl.obolibrary.org/obo/MONDO_0016071) (juvenile hyaline fibromatosis), [MONDO:0011465](http://purl.obolibrary.org/obo/MONDO_0011465) (infundibulocystic basal cell carcinoma), [MONDO:0015821](http://purl.obolibrary.org/obo/MONDO_0015821) (mycosis fungoides and variants), [MONDO:0010017](http://purl.obolibrary.org/obo/MONDO_0010017) (sea-blue histiocyte syndrome), [MONDO:0009691](http://purl.obolibrary.org/obo/MONDO_0009691) (mycosis fungoides), [MONDO:0013510](http://purl.obolibrary.org/obo/MONDO_0013510) (melanoma, cutaneous malignant, susceptibility to, 6), [MONDO:0012183](http://purl.obolibrary.org/obo/MONDO_0012183) (melanoma, cutaneous malignant, susceptibility to, 3), [MONDO:0014368](http://purl.obolibrary.org/obo/MONDO_0014368) (melanoma, cutaneous malignant, susceptibility to, 10), [MONDO:0018961](http://purl.obolibrary.org/obo/MONDO_0018961) (familial melanoma), [MONDO:0017598](http://purl.obolibrary.org/obo/MONDO_0017598) (primary cutaneous anaplastic large cell lymphoma), [MONDO:0014122](http://purl.obolibrary.org/obo/MONDO_0014122) (myofibromatosis, infantile, 2), [MONDO:0019210](http://purl.obolibrary.org/obo/MONDO_0019210) (cutaneous neuroendocrine carcinoma), [MONDO:0020562](http://purl.obolibrary.org/obo/MONDO_0020562) (pleomorphic liposarcoma), [MONDO:0020563](http://purl.obolibrary.org/obo/MONDO_0020563) (Dedifferentiated liposarcoma), [MONDO:0020326](http://purl.obolibrary.org/obo/MONDO_0020326) (lymphomatoid papulosis), [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0020561](http://purl.obolibrary.org/obo/MONDO_0020561) (myxoid/round cell liposarcoma), [MONDO:0015814](http://purl.obolibrary.org/obo/MONDO_0015814) (primary cutaneous follicle center lymphoma), [MONDO:0013759](http://purl.obolibrary.org/obo/MONDO_0013759) (MITF-related melanoma and renal cell carcinoma predisposition syndrome), [MONDO:0015817](http://purl.obolibrary.org/obo/MONDO_0015817) (aggressive primary cutaneous T-cell lymphoma), [MONDO:0015816](http://purl.obolibrary.org/obo/MONDO_0015816) (indolent primary cutaneous T-cell lymphoma), [MONDO:0015811](http://purl.obolibrary.org/obo/MONDO_0015811) (primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma), [MONDO:0011934](http://purl.obolibrary.org/obo/MONDO_0011934) (dermatofibrosarcoma protuberans), [MONDO:0015810](http://purl.obolibrary.org/obo/MONDO_0015810) (primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma), [MONDO:0016748](http://purl.obolibrary.org/obo/MONDO_0016748) (hemangioblastoma), [MONDO:0013876](http://purl.obolibrary.org/obo/MONDO_0013876) (basal cell carcinoma, susceptibility to, 7), [MONDO:0015813](http://purl.obolibrary.org/obo/MONDO_0015813) (primary cutaneous marginal zone b-cell lymphoma), [MONDO:0015812](http://purl.obolibrary.org/obo/MONDO_0015812) (primary cutaneous gamma/delta-positive T-cell lymphoma), [MONDO:0016824](http://purl.obolibrary.org/obo/MONDO_0016824) (myofibromatosis), [MONDO:0013101](http://purl.obolibrary.org/obo/MONDO_0013101) (BCC2), [MONDO:0013102](http://purl.obolibrary.org/obo/MONDO_0013102) (BCC3), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0015285](http://purl.obolibrary.org/obo/MONDO_0015285) (Carney complex), [MONDO:0018031](http://purl.obolibrary.org/obo/MONDO_0018031) (granulomatous slack skin), [MONDO:0018153](http://purl.obolibrary.org/obo/MONDO_0018153) (Erdheim-Chester disease), [MONDO:0015808](http://purl.obolibrary.org/obo/MONDO_0015808) (Folliculotropic mycosis fungoides), [MONDO:0015809](http://purl.obolibrary.org/obo/MONDO_0015809) (localized pagetoid reticulosis), [MONDO:0012137](http://purl.obolibrary.org/obo/MONDO_0012137) (Carney complex-trismus-pseudocamptodactyly syndrome), [MONDO:0006383](http://purl.obolibrary.org/obo/MONDO_0006383) (primary cutaneous diffuse large b-cell lymphoma, leg type), [MONDO:0013104](http://purl.obolibrary.org/obo/MONDO_0013104) (BCC4), [MONDO:0013105](http://purl.obolibrary.org/obo/MONDO_0013105) (BCC5), [MONDO:0008080](http://purl.obolibrary.org/obo/MONDO_0008080) (neurofibromatosis, type Iii, mixed central and peripheral), [MONDO:0011525](http://purl.obolibrary.org/obo/MONDO_0011525) (CNC2), [MONDO:0013106](http://purl.obolibrary.org/obo/MONDO_0013106) (BCC6), 

**Corr. equiv. classes:** [Orphanet:178548](http://www.orpha.net/ORDO/Orphanet_178548), [Orphanet:86879](http://www.orpha.net/ORDO/Orphanet_86879), [Orphanet:293822](http://www.orpha.net/ORDO/Orphanet_293822), [Orphanet:86875](http://www.orpha.net/ORDO/Orphanet_86875), [Orphanet:178540](http://www.orpha.net/ORDO/Orphanet_178540), [OMIM:613061](http://purl.obolibrary.org/obo/OMIM_613061), [OMIM:613063](http://purl.obolibrary.org/obo/OMIM_613063), [Orphanet:178544](http://www.orpha.net/ORDO/Orphanet_178544), [OMIM:155700](http://purl.obolibrary.org/obo/OMIM_155700), [OMIM:613062](http://purl.obolibrary.org/obo/OMIM_613062), [Orphanet:93921](http://www.orpha.net/ORDO/Orphanet_93921), [Orphanet:171901](http://www.orpha.net/ORDO/Orphanet_171901), [Orphanet:319340](http://www.orpha.net/ORDO/Orphanet_319340), [Orphanet:33111](http://www.orpha.net/ORDO/Orphanet_33111), [OMIM:615848](http://purl.obolibrary.org/obo/OMIM_615848), [Orphanet:2584](http://www.orpha.net/ORDO/Orphanet_2584), [Orphanet:2028](http://www.orpha.net/ORDO/Orphanet_2028), [Orphanet:178512](http://www.orpha.net/ORDO/Orphanet_178512), [Orphanet:178557](http://www.orpha.net/ORDO/Orphanet_178557), [Orphanet:31112](http://www.orpha.net/ORDO/Orphanet_31112), [Orphanet:178517](http://www.orpha.net/ORDO/Orphanet_178517), [Orphanet:69078](http://www.orpha.net/ORDO/Orphanet_69078), [OMIM:615293](http://purl.obolibrary.org/obo/OMIM_615293), [OMIM:162260](http://purl.obolibrary.org/obo/OMIM_162260), [Orphanet:178551](http://www.orpha.net/ORDO/Orphanet_178551), [Orphanet:178554](http://www.orpha.net/ORDO/Orphanet_178554), [Orphanet:477742](http://www.orpha.net/ORDO/Orphanet_477742), [OMIM:228550](http://purl.obolibrary.org/obo/OMIM_228550), [OMIM:612263](http://purl.obolibrary.org/obo/OMIM_612263), [OMIM:615134](http://purl.obolibrary.org/obo/OMIM_615134), [Orphanet:79140](http://www.orpha.net/ORDO/Orphanet_79140), [OMIM:605462](http://purl.obolibrary.org/obo/OMIM_605462), [Orphanet:35687](http://www.orpha.net/ORDO/Orphanet_35687), [OMIM:604451](http://purl.obolibrary.org/obo/OMIM_604451), [Orphanet:98842](http://www.orpha.net/ORDO/Orphanet_98842), [Orphanet:542](http://www.orpha.net/ORDO/Orphanet_542), [Orphanet:99970](http://www.orpha.net/ORDO/Orphanet_99970), [Orphanet:541](http://www.orpha.net/ORDO/Orphanet_541), [Orphanet:99971](http://www.orpha.net/ORDO/Orphanet_99971), [Orphanet:300865](http://www.orpha.net/ORDO/Orphanet_300865), [Orphanet:178528](http://www.orpha.net/ORDO/Orphanet_178528), [OMIM:162091](http://purl.obolibrary.org/obo/OMIM_162091), [OMIM:155601](http://purl.obolibrary.org/obo/OMIM_155601), [Orphanet:178522](http://www.orpha.net/ORDO/Orphanet_178522), [Orphanet:178566](http://www.orpha.net/ORDO/Orphanet_178566), [Orphanet:178563](http://www.orpha.net/ORDO/Orphanet_178563), [OMIM:155600](http://purl.obolibrary.org/obo/OMIM_155600), [Orphanet:618](http://www.orpha.net/ORDO/Orphanet_618), [Orphanet:99969](http://www.orpha.net/ORDO/Orphanet_99969), [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), [OMIM:614456](http://purl.obolibrary.org/obo/OMIM_614456), [Orphanet:99967](http://www.orpha.net/ORDO/Orphanet_99967), [OMIM:254400](http://purl.obolibrary.org/obo/OMIM_254400), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359), [OMIM:608837](http://purl.obolibrary.org/obo/OMIM_608837), [OMIM:160980](http://purl.obolibrary.org/obo/OMIM_160980), [Orphanet:178536](http://www.orpha.net/ORDO/Orphanet_178536), [Orphanet:252054](http://www.orpha.net/ORDO/Orphanet_252054), [Orphanet:3162](http://www.orpha.net/ORDO/Orphanet_3162), [Orphanet:2591](http://www.orpha.net/ORDO/Orphanet_2591), [Orphanet:158029](http://www.orpha.net/ORDO/Orphanet_158029), [Orphanet:178533](http://www.orpha.net/ORDO/Orphanet_178533), [OMIM:269600](http://purl.obolibrary.org/obo/OMIM_269600), [OMIM:607907](http://purl.obolibrary.org/obo/OMIM_607907), [Orphanet:86885](http://www.orpha.net/ORDO/Orphanet_86885), [OMIM:615670](http://purl.obolibrary.org/obo/OMIM_615670), [Orphanet:86884](http://www.orpha.net/ORDO/Orphanet_86884), [OMIM:614740](http://purl.obolibrary.org/obo/OMIM_614740), [OMIM:613099](http://purl.obolibrary.org/obo/OMIM_613099), [OMIM:613058](http://purl.obolibrary.org/obo/OMIM_613058), [OMIM:613972](http://purl.obolibrary.org/obo/OMIM_613972), [OMIM:613059](http://purl.obolibrary.org/obo/OMIM_613059), [OMIM:608035](http://purl.obolibrary.org/obo/OMIM_608035), [OMIM:605244](http://purl.obolibrary.org/obo/OMIM_605244), [OMIM:609048](http://purl.obolibrary.org/obo/OMIM_609048), 

**Class expressions from DL-Learner:**

- Thing 23.49%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 23.49%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 23.07%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 22.08%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 20.98%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 20.91%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 20.91%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 20.91%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 20.90%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 20.90%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 20.90%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 20.06%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 19.45%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) 19.22%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 17.13%


